Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Back to the letter...borredo
5
Jan 30, 2008 04:25AM
1
Jan 30, 2008 04:37AM
2
Jan 30, 2008 04:49AM

Besides like I've said 50/60M shares sounds good but little over 11% is not that meaningful when you consider 500M shares outstanding.

So ... the impact that Swartz has had while holding a comparable number of shares is also "not that meaningful"? IMO, shareholders representing 11% of shares outstanding can have a considerable impact.

2
Jan 30, 2008 07:37AM
7
Jan 30, 2008 07:56AM
3
Jan 30, 2008 08:30AM
1
Jan 30, 2008 08:35AM
1
Jan 30, 2008 08:42AM
5
Jan 30, 2008 08:44AM
1
Jan 30, 2008 08:44AM
1
Jan 30, 2008 08:47AM
2
Jan 30, 2008 08:57AM
3
Jan 30, 2008 09:08AM

Jan 30, 2008 09:44AM
1
Jan 30, 2008 09:46AM

Jan 30, 2008 02:57PM
Share
New Message
Please login to post a reply